Enrique Samper Rodriguez

Vorstandsvorsitzender bei NIMGenetics Genómica y Medicina SL

Health Technology

Commercial Services

Profil

Enrique Samper Rodriguez is the founder and current Director of Gene Predictis SA. He founded NIMGenetics Genómica y Medicina SL in 2008 and serves as its Chief Executive Officer.

Aktive Positionen von Enrique Samper Rodriguez

Unternehmen	Position	Beginn
NIMGenetics Genómica y Medicina SL NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain.	Vorstandsvorsitzender	01.01.2008
GENE PREDICTIS SA GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023.	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Enrique Samper Rodriguez

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Enrique Samper Rodriguez im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
NIMGenetics Genómica y Medicina SL NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain.	Health Technology
GENE PREDICTIS SA GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023.	Commercial Services